As some of you may be aware, MMJ today’s holding company was recently served with a lawsuit pertaining to the alleged defamation of a certain writer who covers micro-cap stocks trading on the OTC. This writer in particular had frequently written hit pieces on an MMJ company we cover, called Creative Edge Nutrition (FITX) over the course of a 1 …
Read More »
CEN Biotech Inc, a wholly owned Canadian subsidiary of the hotly debated publicly traded company Creative edge nutrition (OTC: FITX) which is actively engaged in seeking a licence to grow marijuana under Canada’s newly formed MMPR, filed it’s quarterly financials last week on the OTC markets. Both the company and it’s CEO, Dr. Bill Chaaban, who is a licensed attorney in both …
Read More »
In light of recent developments surrounding an alleged campaign to destroy the publicly traded company’s share price. CEN Biotech (OTC: FITX), a Canadian subsidiary actively engaged in seeking a licence to grow marijuana under Canada’s newly formed MMPR, has had approximately 100 documented negative and defamatory articles written against the company over the span of just 1 year, almost exclusively (60+) …
Read More »
Collaboration: from the Latin word collaboratus, a past participle of collaborare “to labor together”, from Latin com- + laborare to labor. In a letter dated January 13th, 2014 from the Licences and Permits Division of Health Canada’s Office of Controlled Substances, CEN Biotechs CEO, Mr. Bill Chaaban is personally thanked for his collaboration with Health Canada through the licensing process …
Read More »
Capricious Actions by Health Canada Causing Detrimental Reliance to MMPR Applicants Health Canada plays favorites with MMPR Applicants and LPs. Arbitrary behavior towards applicants by Health Canada. Health Canada lacks placement of, or effective adherence to internal SOP’s. Health Canada’s internal system broken. Corrective actions required. Health Canada has demonstrated a clear lack of diligence through capricious actions towards applicants …
Read More »
“Work hard in silence, and let your success make the noise” is the most apt quote that comes to mind when we consider the patience of investors throughout CEN Biotech’s 90 day Quiet Period, ending shortly on Feb. 17th 2015. In the face of bashers and their misplaced skepticism, CEN Biotech will soon be making another strategicallyok well-timed spin off …
Read More »
CEN Biotech shows strong uptrend despite attempts by detractors to confuse new investors. Last week, following some very positive news about the direction that Creative Edge Nutrition (ticker Symbol FITX) is taking from new CEO James Robinson, the company gained more then 100% in its stock price. There was also mention of an updated website that will make it’s appearance …
Read More »
This will be part 2 in a series of articles aimed at exposing the corruption around the Canadian MMPR process and speculative agenda of parties involved. In this article, I would like to expound upon some of the details of certain individuals efforts, as well as provide some background for character reference to aid in context. Please note that readers …
Read More »
Canadian Cannabis Corruption… Yes, I thought that might just get your attention. And for good reason. You see, there is a storm brewing in the wake of Canada’s MMPR program. A tale of political ties, competitive agendas, and conflicts of interest. I would firstly like to thank one Mr. Grant Robertson of the Globe and Mail for initiating this investigation, …
Read More »
MMJ.TODAY Science. Unbound